Probiotics for the prevention of allergic disease

Clinical and Experimental Allergy

Volumn 42, Issue 7, 2012, Pages 991-993

  Kuitunen, M ^a   Boyle, R J ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 10; PROBIOTIC AGENT;

ALLERGIC DISEASE; BIFIDOBACTERIUM ANIMALIS; BREAST MILK; CLINICAL EFFECTIVENESS; DRUG EFFICACY; ECZEMA; EDITORIAL; HELMINTHIASIS; HUMAN; LACTOBACILLUS RHAMNOSUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHINOCONJUNCTIVITIS; TREATMENT OUTCOME;

HUMANS; HYPERSENSITIVITY; PROBIOTICS;

EID: 84862553975     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.04023.x     Document Type: Editorial

References (21)

1. Foisy M, Boyle RJ, Chalmers JR, Simpson EL, Williams HC. The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews. Evid-Based Child Health 2011; 6:1322-9.
2. Gerrard JW, Geddes CA, Reggin PL, Gerrard CD, Horne S. Serum IgE levels in white and metis communities in Saskatchewan. Ann Allergy 1976;37:91-100.
3. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9.
4. Pelucchi C, Chatenoud L, Turati F et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012;23:402-14.
5. Kukkonen K, Savilahti E, Haahtela T et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-8.
6. Kuitunen M, Kukkonen K, Juntunen-Backman K et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123:335-41.
7. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008; 121:e850-6.
8. West CE, Hammarstrom ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009; 20:430-7.
9. Boyle RJ, Ismail IH, Kivivuori S et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011;66:509-16.
10. Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010;163:616-23.
11. Huurre A, Laitinen K, Rautava S, Korkeamaki M, Isolauri E. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy 2008; 38:1342-8.
12. Lau S, Gerhold K, Zimmermann K et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2012;129:1040-7.
13. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516-20.
14. Adlerberth I, Strachan DP, Matricardi PM et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007; 120:343-50.
15. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000; 66:2578-88.
16. Marschan E, Kuitunen M, Kukkonen K et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008; 38:611-8.
17. Prescott SL, Wickens K, Westcott L et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy 2008;38:1606-14.
18. Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80.
19. Hunt KM, Foster JA, Forney LJ et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS ONE 2011;6:e21313.
20. EFSA Panel on Dietetic Products NaAN. Frequently Asked Questions (FAQ) related to the assessment of Article 14 and 13.5 health claims applications on request of EFSA. EFSA Journal 2009;7:1339.
21. Wickens K, Black P, Stanley TV et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012;42:1071-9.